Ausgabe 3/2006
Inhalt (8 Artikel)
Second-line strategies for metastatic renal cell carcinoma: classics and novel approaches
A. J. Schrader, Z. Varga, A. Hegele, S. Pfoertner, P. Olbert, R. Hofmann
Hsp90 inhibitors cause G2/M arrest associated with the reduction of Cdc25C and Cdc2 in lung cancer cell lines
Megumi Senju, Naoko Sueoka, Akemi Sato, Kentaro Iwanaga, Yukinori Sakao, Shinji Tomimitsu, Masaki Tominaga, Koji Irie, Shinichiro Hayashi, Eisaburo Sueoka
MYH Y165C and G382D mutations in hepatocellular carcinoma and cholangiocarcinoma patients
Linnea M. Baudhuin, Lewis R. Roberts, Felicity T.B. Enders, Russell L. Swanson, Teresa A. Mettler, Ileana Aderca, Linda M. Stadheim, W. Edward Highsmith
Cyclin-dependant kinase inhibitors CIP1 (p21) and KIP1 (p27) in ovarian cancer
Annette Schmider-Ross, Olaf Pirsig, Elisabeth Gottschalk, Carsten Denkert, Werner Lichtenegger, Angela Reles
Cathepsin B mediates TRAIL-induced apoptosis in oral cancer cells
Nagathihalli S. Nagaraj, Nadarajah Vigneswaran, Wolfgang Zacharias
Cyclooxygenase-2 (COX-2) is directly involved but not decisive in proliferation of human hepatocellular carcinoma cells
Joong-Won Park, Jung Eun Park, Jung Ahn Lee, Chang-Woo Lee, Chang-Min Kim
Elevated risk of colorectal cancer associated with the AA genotype of the cyclin D1 A870G polymorphism in an Indian population
Jing Jiang, Jingweng Wang, Sadao Suzuki, Vendhan Gajalakshmi, Kiyonori Kuriki, Yang Zhao, Seiichi Nakamura, Susumu Akasaka, Hideki Ishikawa, Shinkan Tokudome
Loss of heterozygosity testing using real-time PCR analysis of single nucleotide polymorphisms
Tamara Čačev, Mladen Jokić, Radan Spaventi, Krešimir Pavelić, Sanja Kapitanović